Clinical Trial Update: Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating a mesothelin-targeted CAR T-cell therapy in malignant pleural mesothelioma. The study status is active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Mesothelin-targeted CAR T-cell therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Malignant Pleural Mesothelioma (MPM) | Phase 1 | Status: ACTIVE_NOT_RECRUITING